| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68254-5006-1 | 68254-5006 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201123 | N/A | ANDA | ANDA213112 | CONCORD BIOTECH LIMITED | TACROLIMUS | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (68254-5006-1) |
| 68254-5006-5 | 68254-5006 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201123 | N/A | ANDA | ANDA213112 | CONCORD BIOTECH LIMITED | TACROLIMUS | 5 mg/1 | 30 CAPSULE in 1 BOTTLE (68254-5006-5) |
| 68254-5004-1 | 68254-5004 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201123 | N/A | ANDA | ANDA213112 | CONCORD BIOTECH LIMITED | TACROLIMUS | .5 mg/1 | 100 CAPSULE in 1 BOTTLE (68254-5004-1) |
| 68254-5004-5 | 68254-5004 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201123 | N/A | ANDA | ANDA213112 | CONCORD BIOTECH LIMITED | TACROLIMUS | .5 mg/1 | 30 CAPSULE in 1 BOTTLE (68254-5004-5) |
| 68254-5005-1 | 68254-5005 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201123 | N/A | ANDA | ANDA213112 | CONCORD BIOTECH LIMITED | TACROLIMUS | 1 mg/1 | 100 CAPSULE in 1 BOTTLE (68254-5005-1) |
| 68254-5005-5 | 68254-5005 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201123 | N/A | ANDA | ANDA213112 | CONCORD BIOTECH LIMITED | TACROLIMUS | 1 mg/1 | 30 CAPSULE in 1 BOTTLE (68254-5005-5) |